Literature DB >> 10688866

DNA methylation: past, present and future directions.

K D Robertson1, P A Jones.   

Abstract

DNA methylation, or the covalent addition of a methyl group to cytosine within the context of the CpG dinucleotide, has profound effects on the mammalian genome. These effects include transcriptional repression via inhibition of transcription factor binding or the recruitment of methyl-binding proteins and their associated chromatin remodeling factors, X chromosome inactivation, imprinting and the suppression of parasitic DNA sequences. DNA methylation is also essential for proper embryonic development; however, its presence can add an additional burden to the genome. Normal methylation patterns are frequently disrupted in tumor cells with global hypomethylation accompanying region-specific hypermethylation. When these hypermethylation events occur within the promoter of a tumor suppressor gene they will silence the gene and provide the cell with a growth advantage in a manner akin to deletions or mutations. Recent work indicating that DNA methylation is an important player in both DNA repair and genome stability as well as the discovery of a new family of DNA methyltransferases makes now a very exciting period for the methylation field. This review will highlight the major findings in the methylation field over the past 20 years then summarize the most important and interesting future directions the field is likely to take in the next millennium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688866     DOI: 10.1093/carcin/21.3.461

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  139 in total

Review 1.  The biology of the mammalian Krüppel-like family of transcription factors.

Authors:  D T Dang; J Pevsner; V W Yang
Journal:  Int J Biochem Cell Biol       Date:  2000 Nov-Dec       Impact factor: 5.085

2.  Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density.

Authors:  Oliver Galm; Michael R Rountree; Kurtis E Bachman; Kam-Wing Jair; Stephen B Baylin; James G Herman
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

3.  Lsh, a member of the SNF2 family, is required for genome-wide methylation.

Authors:  K Dennis; T Fan; T Geiman; Q Yan; K Muegge
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

4.  Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology.

Authors:  J Cui; D H Yang; X J Bi; Z R Fan
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 5.  Above and within the genome: epigenetics past and present.

Authors:  F D Urnov; A P Wolffe
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

6.  Methylation patterns and mathematical models reveal dynamics of stem cell turnover in the human colon.

Authors:  S Ro; B Rannala
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

7.  Investigating stem cells in human colon by using methylation patterns.

Authors:  Y Yatabe; S Tavaré; D Shibata
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

8.  Strand-biased DNA methylation associated with centromeric regions in Arabidopsis.

Authors:  Song Luo; Daphne Preuss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

Review 9.  Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Authors:  Oliver Galm; Manel Esteller
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

10.  Detection of allelic imbalance in the gene expression of hMSH2 or RB1 in lymphocytes from pedigrees of hereditary, nonpolyposis, colorectal cancer and retinoblastoma by an RNA difference plot.

Authors:  Yoshinori Murakami; Kana Isogai; Hiroyuki Tomita; Mika Sakurai-Yageta; Tomoko Maruyama; Akio Hidaka; Kiyoshi Nose; Kokichi Sugano; Akihiro Kaneko
Journal:  J Hum Genet       Date:  2004-10-08       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.